Cytosorbents
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Cytosorbents's past years’ income statements indicate that its last revenue has increased compared to the previous period by 24% to $36,349,379. The net income raised on -$28,507,394 and profit margin reached -78%. Total operating expenses were $53,601,276.
Profit Margin
| 2014 | 3.14M | -9.32M | -296.38% |
|---|---|---|---|
| 2015 | 4.05M | -8.13M | -200.5% |
| 2016 | 8.20M | -11.93M | -145.49% |
| 2017 | 13.38M | -8.46M | -63.23% |
| 2018 | 20.25M | -17.21M | -84.98% |
| 2019 | 22.76M | -19.26M | -84.63% |
| 2020 | 39.45M | -7.83M | -19.86% |
| 2021 | 40.10M | -24.55M | -61.23% |
| 2022 | 29.36M | -32.81M | -111.76% |
| 2023 | 36.34M | -28.50M | -78.43% |
CTSO Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 36.34M | 29.36M | 40.10M | 39.45M | 22.76M | 20.25M | 13.38M | 8.20M | 4.05M | 3.14M |
Cost of revenue | 13.95M | 13.95M | 11.04M | 11.05M | 7.36M | 7.48M | 5.51M | 3.95M | 2.21M | 2.13M |
Gross profit | 22.39M | 15.40M | 29.06M | 28.4M | 15.40M | 12.76M | 7.86M | 4.25M | 1.84M | 1.01M |
Operating exp. | ||||||||||
Research and development | 15.72M | 15.11M | 16.38M | 8.81M | 12.09M | 7.72M | 4.04M | 4.78M | 3.87M | 2.43M |
Selling and marketing | 253K | 582K | 615K | 285K | 314K | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 53.60M | 46.92M | 51.80M | 38.77M | 34.37M | 28.34M | 17.70M | 15.74M | 11.14M | 8.29M |
Operating income | -31.20M | -31.52M | -22.74M | -10.37M | -18.97M | -15.58M | -9.84M | -11.49M | -9.30M | -7.27M |
Other income (expenses), net | 1.88M | -2.38M | -2.55M | 1.40M | -1.38M | -784.75K | 705.06K | -533.49K | 847.31K | -2.81M |
Income before tax | -29.32M | -33.90M | -25.29M | -8.96M | -20.35M | -17.83M | -9.13M | -12.25M | -8.45M | -9.70M |
Income tax expense | -813.73K | -1.09M | -736K | -1.12M | -1.09M | -619.54K | -676.73K | -318.55K | -324.60K | -386K |
Net income | -28.50M | -32.81M | -24.55M | -7.83M | -19.26M | -17.21M | -8.46M | -11.93M | -8.13M | -9.32M |
Earnings per share | ||||||||||
Basic EPS | -0.64 | -0.75 | -0.57 | -0.2 | -0.6 | -0.56 | -0.31 | -0.47 | -0.33 | -0.65 |
Diluted EPS | -0.64 | -0.75 | -0.57 | -0.2 | -0.6 | -0.56 | -0.31 | -0.47 | -0.33 | -0.65 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |